Cargando…

Biglycan: A Multivalent Proteoglycan Providing Structure and Signals

Research over the past few years has provided fascinating results indicating that biglycan, besides being a ubiquitous structural component of the extracellular matrix (ECM), may act as a signaling molecule. Proteolytically released from the ECM, biglycan acts as a danger signal signifying tissue st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nastase, Madalina V., Young, Marian F., Schaefer, Liliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527886/ https://www.ncbi.nlm.nih.gov/pubmed/22821552 http://dx.doi.org/10.1369/0022155412456380

Ejemplares similares

Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants
por: Hsieh, Louise Tzung-Harn, et al.
Publicado: (2017)

The Role of Decorin and Biglycan Signaling in Tumorigenesis
por: Diehl, Valentina, et al.
Publicado: (2021)

The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness
por: Pinto, Filipe, et al.
Publicado: (2021)

Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
por: Niedworok, Christian, et al.
Publicado: (2013)

Biglycan regulates bone development and regeneration
por: Shainer, Reut, et al.
Publicado: (2023)

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
por: Morimoto, Hirofumi, et al.
Publicado: (2021)

The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
por: Hoermann, Henrike, et al.
Publicado: (2021)

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle
por: Bowe, Mark A., et al.
Publicado: (2000)

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
por: Iozzo, Renato V., et al.
Publicado: (2015)

Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease
por: Fadic, Ricardo, et al.
Publicado: (2006)

Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases
por: Halari, Chidambra D., et al.
Publicado: (2021)

Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site
por: Monfort, Jordi, et al.
Publicado: (2006)

Correction: Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease 13 - identification of a new biglycan cleavage site
por: Monfort, Jordi, et al.
Publicado: (2013)

The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes
por: Bolton, Kristy, et al.
Publicado: (2012)

Coordinate roles for collagen VI and biglycan in regulating tendon collagen fibril structure and function
por: Leiphart, Ryan J., et al.
Publicado: (2021)

Breast cancer dataset with biomarker Biglycan
por: Silva Neto, Pedro Clarindo da, et al.
Publicado: (2023)

Global impact of proteoglycan science on human diseases
por: Xie, Christopher, et al.
Publicado: (2023)

Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
por: Cong, Li, et al.
Publicado: (2021)

The matricellular functions of small leucine-rich proteoglycans (SLRPs)
por: Merline, Rosetta, et al.
Publicado: (2009)

Biglycan enhances gastric cancer invasion by activating FAK signaling pathway
por: Hu, Lei, et al.
Publicado: (2014)

Expression and the Prognostic Value of Biglycan in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2022)

Biglycan expression and its function in human ligamentum flavum
por: Salimi, Hamidullah, et al.
Publicado: (2021)

Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis
por: Barreto, Goncalo, et al.
Publicado: (2015)

Decorin knockdown is beneficial for aged tendons in the presence of biglycan expression
por: Beach, Zakary M., et al.
Publicado: (2022)

Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers
por: Zhao, Shou-Feng, et al.
Publicado: (2020)

Uterine Dysfunction in Biglycan and Decorin Deficient Mice Leads to Dystocia during Parturition
por: Wu, Zhiping, et al.
Publicado: (2012)

Identification of the effector domain of biglycan that facilitates BMP-2 osteogenic function
por: Jongwattanapisan, Prapaporn, et al.
Publicado: (2018)

Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth
por: Mennella, Jenna M., et al.
Publicado: (2020)

Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

IPSC reprogramming of two patients with spondyloepimetaphyseal dysplasia (SEMD, biglycan type)
por: De Kinderen, Pauline, et al.
Publicado: (2023)

Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
por: Sunderland, Ashley, et al.
Publicado: (2023)

Small leucine rich proteoglycans, a novel link to osteoclastogenesis
por: Kram, Vardit, et al.
Publicado: (2017)

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases
por: Zeng-Brouwers, Jinyang, et al.
Publicado: (2020)

Biglycan Promotes Cancer Stem Cell Properties, NFκB Signaling and Metastatic Potential in Breast Cancer Cells
por: Manupati, Kanakaraju, et al.
Publicado: (2022)

Celastrol Induces Necroptosis and Ameliorates Inflammation via Targeting Biglycan in Human Gastric Carcinoma
por: Guo, Dandan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j9vld5ur9kcent05bjj5v1h6lr